927 results on '"Pallansch, Mark"'
Search Results
2. Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial
3. Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020
4. Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial
5. Progress Toward Poliovirus Containment Implementation — Worldwide, 2019–2020
6. Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial
7. Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2018–June 2019
8. Certifying the interruption of wild poliovirus transmission in the WHO African region on the turbulent journey to a polio-free world
9. Increase in Acute Flaccid Myelitis — United States, 2018
10. Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models : Support for at least 2 Doses
11. Progress in poliovirus containment--worldwide, 2019-2020/Progres du confinement des poliovirus dans le monde, 2019-2020
12. Update on vaccine-derived Polioviruses--worldwide, January 2018-June 2019/Le point sur les poliovirus derives d'une souche vaccinale dans le monde, janvier 2018-juin 2019
13. Worst‐case scenarios: Modeling uncontrolled type 2 polio transmission.
14. Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences.
15. The seasonality of nonpolio enteroviruses in the United States : Patterns and drivers
16. Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial
17. Outbreak of Neurologic Enterovirus Type 71 Disease: A Diagnostic Challenge
18. Emergence of Echovirus Type 13 as a Prominent Enterovirus
19. The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks
20. Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States
21. Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences
22. Worst‐case scenarios: Modeling uncontrolled type 2 polio transmission
23. An Echovirus Type 33 Winter Outbreak in New Zealand
24. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
25. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule
26. Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus
27. Deaths of Children during an Outbreak of Hand, Foot, and Mouth Disease in Sarawak, Malaysia: Clinical and Pathological Characteristics of the Disease
28. Viral Meningitis in Child Care Center Staff and Parents: An Outbreak of Echovirus 30 Infections
29. Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide Surveillance
30. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial
31. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation
32. Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: Evaluation of adapting polio and measles laboratory networks in Bangladesh, China and India, 2007–2008
33. Circulating Poliovirus in New York — New Instance of an Old Problem
34. Outbreak response strategies with type 2-containing oral poliovirus vaccines
35. Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems
36. CDC's Early Response to a Novel Viral Disease, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), September 2012-May 2014
37. Modeling Options to Manage Type 1 Wild Poliovirus Imported Into Israel in 2013
38. Update on the Epidemiology of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection, and Guidance for the Public, Clinicians, and Public Health Authorities — January 2015
39. Polio Eradicators Use Integrated Analytical Models to Make Better Decisions
40. Clinical and Laboratory Findings of the First Imported Case of Middle East Respiratory Syndrome Coronavirus to the United States
41. Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description
42. Effect of Buffer on the Immune Response to Trivalent Oral Poliovirus Vaccine in Bangladesh: A Community Based Randomized Controlled Trial
43. A World Without Polio
44. Outbreak of Type 1 Wild Poliovirus Infection in Adults, Namibia, 2006
45. Detection of Vaccine-Derived Polioviruses in Mexico Using Environmental Surveillance
46. Assessing Population Immunity in a Persistently High-Risk Area for Wild Poliovirus Transmission in India: A Serological Study in Moradabad, Western Uttar Pradesh
47. Progress in the Development of Poliovirus Antiviral Agents and Their Essential Role in Reducing Risks That Threaten Eradication
48. Prevalence of Asymptomatic Poliovirus Infection in Older Children and Adults in Northern India: Analysis of Contact and Enhanced Community Surveillance, 2009
49. Switch From Oral to Inactivated Poliovirus Vaccine in Yogyakarta Province, Indonesia: Summary of Coverage, Immunity, and Environmental Surveillance
50. Estimating the Likely Coverage of Inactivated Poliovirus Vaccine in Routine Immunization: Evidence From Demographic and Health Surveys
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.